EPN2

Chr 17

epsin 2

Also known as: EHB21

The protein participates in clathrin-mediated endocytosis by interacting with clathrin and adaptor proteins, localizing to the peri-Golgi region and cell periphery. Mutations cause autosomal recessive developmental and epileptic encephalopathy with onset in infancy, characterized by severe intellectual disability, refractory seizures, and progressive microcephaly. The gene shows moderate constraint against loss-of-function variants (LOEUF 0.397), consistent with its recessive inheritance pattern.

ResearchSummary from RefSeq, UniProt
LOEUF 0.40
Clinical SummaryEPN2
Population Constraint (gnomAD)
Moderately constrained gene (pLI 0.75) — some intolerance to loss-of-function variants.
Some data sources returned errors (1)

omim: Error: OMIM fetch failed: 429

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Moderate LoF intolerance
LoF Constraint
0.40LOEUF
pLI 0.748
Z-score 3.87
OE 0.19 (0.100.40)
Moderately constrained

More LoF-intolerant than ~75% of genes

Missense Constraint
1.39Z-score
OE missense 0.80 (0.730.88)
301 obs / 376.8 exp
Tolerant

Mild missense constraint

Observed / Expected Ratios
LoF OE0.19 (0.100.40)
00.351.4
Missense OE0.80 (0.730.88)
00.61.4
Synonymous OE0.86
01.21.6
LoF obs/exp: 5 / 26.5Missense obs/exp: 301 / 376.8Syn Z: 1.45

ClinVar Variant Classifications

0 submitted variants in ClinVar

Protein Context — Lollipop Plot

EPN2 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

3D Protein StructureAlphaFold

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →